0 likes | 18 Views
Analysis of Microbiology Testing Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~7% During 2023-2035 and Attain ~USD 10 Billion by 2035<br>
E N D
Analysis of Microbiology Testing Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~7% During 2023-2035 and Attain ~USD 10 Billion by 2035 Research Nester assesses the growth and market size of global microbiology testing market which is anticipated to be on account of the growing demand for rapid diagnostic tests, rising demand for food safety testing. New York – June 19, 2023 - Research Nester’s recent market research analysis on “Microbiology Testing Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitors analysis and a detailed overview of the global microbiology testing market in terms of market segmentation by test type, product, diseases, application and by region.
Increasing Prevalence of Infectious Diseases to Promote Global Market Share of Microbiology Testing The global microbiology testing market is estimated to grow majorly on account of rise in the prevalence of infectious diseases such as STDs, HIV-AIDS, seasonal influenza. WHO estimates that over 1 million STIs are acquired worldwide each day. There have been 650 000 HIV-related deaths and 1.5 million HIV infections in 2021. In response to population growth, increased travel, and climate change, the risk of infectious diseases has been on the rise. This has resulted in an increased demand for more accurate and efficient testing methods, which has in turn driven the growth of the global microbiology testing market.
Some of the major growth factors and challenges that are associated with the growth of the global microbiology testing market are: Growth Drivers: Rising demand for food safety testing · · Growing efforts by governments to control the spread of infectious diseases Challenges: The inability of tests to accurately detect the presence of pathogens or correctly identify a pathogen’s strain is a major concern for the industry. This can lead to incorrect treatments and the spread of disease, which can potentially have a negative impact on the growth of the market. Moreover, the high cost of advanced technologies, shortage of skilled professionals, and the time-consuming nature of the tests are also expected to impede market growth. Access our detailed report at: https://www.researchnester.com/reports/microbiology-testing- market/5065 By application the global microbiology testing market is segmented into pharmaceutical, clinical, food testing, energy, chemical and others. The pharmaceutical segment is to garner a highest revenue by the end of 2035 by growing at a significant CAGR over the forecast period on account of the rise in the number of pharmaceutical companies and the increasing demand for quality microbial testing in order to determine the safety and
efficacy of drugs. Additionally, the introduction of advancing technologies such as DNA sequencing, PCR and microarrays is further driving the growth of the segment. By region, the North America microbiology testing market is expected to generate the highest revenue by the end of 2035. This growth is anticipated by the presence of a large number of established players and the growing demand for the testing of water, food, and other products. Additionally, the presence of advanced healthcare infrastructure and increasing food-borne illness prevalence is expected to further drive the market in North America. As food safety regulations become more strict, food producers are turning to microbiology testing to ensure their products are safe for consumption. Microbiology testing helps identify potential pathogens, allergens, bacteria, and other contaminants that can cause illness. Furthermore, among all other areas, the microbiology testing market in Europe is expected to hold the bulk of the share by the end of 2035. The market's expansion can be traced mostly to the increase in the number of new drug approvals, growth in the biopharmaceutical industry, and government initiatives to promote the development of new diagnostic technologies such as Innovative Medicines Initiative (IMI). This initiative aims to accelerate the advancement of better and safer treatments for patients through a public-private partnership. This report also provides the existing competitive scenario of some of the key players of the Neogen Corporation., STEMart, Masimo, Koninklijke Philips N.V., GE Healthcare, Cerner Corporation, Medtronic Plc, Stryker, iHealth Labs Inc., Cisco.
Request Report Sample@ https://www.researchnester.com/sample-request-5065 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919